US Stock MarketDetailed Quotes

CTOR Citius Oncology

Watchlist
  • 1.300
  • +0.110+9.24%
Close Jan 3 16:00 ET
  • 1.310
  • +0.010+0.77%
Post 19:55 ET
93.02MMarket Cap-4.39P/E (TTM)

Citius Oncology Key Stats

Citius Oncology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 5.736M--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 5.736M--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

Citius Oncology Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 1, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data